UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 2.256

Sortiert nach

Self-Exciting Fluid Dynamos

1, 2019

Volltextzugriff (PDF)

The sigma-1 receptor modulates methamphetamine dysregulation of dopamine neurotransmission

Nature communications, 2017-12, Vol.8 (1), p.2228-18, Article 2228

2017

Volltextzugriff (PDF)

Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate versus ritonavir-boosted atazanavir plus co-formulated emtricitabine and tenofovir disoproxil fumarate for initial treatment of HIV-1 infection: a randomised, double-blind, phase 3, non-inferiority trial

The Lancet (British edition), 2012-06, Vol.379 (9835), p.2429-2438

2012

Volltextzugriff (PDF)

Membrane potential shapes regulation of dopamine transporter trafficking at the plasma membrane

Nature communications, 2016-01, Vol.7 (1), p.10423-10423, Article 10423

2016

Volltextzugriff (PDF)

Brief Report: Long-Term (96-Week) Efficacy and Safety After Switching From Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in HIV-Infected, Virologically Suppressed Adults

Journal of acquired immune deficiency syndromes (1999), 2017-06, Vol.75 (2), p.226

2017

Volltextzugriff (PDF)

Incidence of AIDS-Defining Opportunistic Infections in a Multicohort Analysis of HIV-infected Persons in the United States and Canada, 2000–2010

The Journal of infectious diseases, 2016-09, Vol.214 (6), p.862-872

2016

Volltextzugriff (PDF)

Once-daily dolutegravir versus darunavir plus ritonavir for treatment-naive adults with HIV-1 infection (FLAMINGO): 96 week results from a randomised, open-label, phase 3b study

The lancet HIV, 2015-04, Vol.2 (4), p.e127-e136

2015

Volltextzugriff (PDF)

Switching to coformulated elvitegravir, cobicistat, emtricitabine, and tenofovir versus continuation of non-nucleoside reverse transcriptase inhibitor with emtricitabine and tenofovir in virologically suppressed adults with HIV (STRATEGY-NNRTI): 48 week results of a randomised, open-label, phase 3b non-inferiority trial

The Lancet infectious diseases, 2014-07, Vol.14 (7), p.590-599

2014

Volltextzugriff (PDF)

The two Na+ sites in the human serotonin transporter play distinct roles in the ion coupling and electrogenicity of transport

The Journal of biological chemistry, 2014-01, Vol.289 (3), p.1825-1840

2014

Volltextzugriff (PDF)

SLC6 transporters: Structure, function, regulation, disease association and therapeutics

Molecular aspects of medicine, 2013-04, Vol.34 (2-3), p.197-219

2013

Volltextzugriff (PDF)

Progression of Carotid Intima-Media Thickness in a Contemporary Human Immunodeficiency Virus Cohort

Clinical infectious diseases, 2011-10, Vol.53 (8), p.826-835

2011

Volltextzugriff (PDF)

Viscous Thread Falling on a Spinning Surface

Symmetry (Basel), 2022-08, Vol.14 (8), p.1550

2022

Volltextzugriff (PDF)

Human Serotonin Transporter Coding Variation Establishes Conformational Bias with Functional Consequences

ACS chemical neuroscience, 2019-07, Vol.10 (7), p.3249-3260

2019

Volltextzugriff (PDF)

Tyr-95 and Ile-172 in Transmembrane Segments 1 and 3 of Human Serotonin Transporters Interact to Establish High Affinity Recognition of Antidepressants

The Journal of biological chemistry, 2006-01, Vol.281 (4), p.2012-2023

2006

Volltextzugriff (PDF)

IMPROVE: a feature model to predict neoepitope immunogenicity through broad-scale validation of T-cell recognition

Frontiers in immunology, 2024-04, Vol.15, p.1360281-1360281

2024

Volltextzugriff (PDF)

Stereoselective inhibition of serotonin transporters by antimalarial compounds

Neurochemistry international, 2014-07, Vol.73, p.98-106

2014

Volltextzugriff (PDF)

Immunologic predictors of coronary artery calcium progression in a contemporary HIV cohort

AIDS (London), 2014-03, Vol.28 (6), p.831-840

2014

Volltextzugriff (PDF)

Increasing procaspase 8 expression using repurposed drugs to induce HIV infected cell death in ex vivo patient cells

PloS one, 2017-06, Vol.12 (6), p.e0179327-e0179327

2017

Volltextzugriff (PDF)

Angiotensin converting enzyme inhibitor and HMG-CoA reductase inhibitor as adjunct treatment for persons with HIV infection: a feasibility randomized trial

PloS one, 2012-10, Vol.7 (10), p.e46894

2012

Volltextzugriff (PDF)

Intravenous Fat Emulsion Does Not Significantly Alter Clotting Markers in Dabigatran-Treated Blood

Indian journal of hematology & blood transfusion, 2021-01, Vol.37 (1), p.101-107

2021

Volltextzugriff (PDF)

Guidelines for the Evaluation and Management of Dyslipidemia in Human Immunodeficiency Virus (HIV)-Infected Adults Receiving Antiretroviral Therapy: Recommendations of the HIV Medicine Association of the Infectious Disease Society of America and the Adult AIDS Clinical Trials Group

Clinical infectious diseases, 2003-09, Vol.37 (5), p.613-627

2003

Volltextzugriff (PDF)

Post-translational mechanisms in psychostimulant-induced neurotransmitter efflux

Advances in pharmacology (1990), 2024, Vol.99, p.1

2024

Volltextzugriff (PDF)

CD4+ count and risk of non-AIDS diseases following initial treatment for HIV infection

AIDS (London), 2008-04, Vol.22 (7), p.841-848

2008

Volltextzugriff (PDF)

Monocyte-Activation Phenotypes Are Associated With Biomarkers of Inflammation and Coagulation in Chronic HIV Infection

The Journal of infectious diseases, 2014-11, Vol.210 (9), p.1396-1406

2014

Volltextzugriff (PDF)

Taurine treatment of retinal degeneration and cardiomyopathy in a consanguineous family with SLC6A6 taurine transporter deficiency

Human molecular genetics, 2020-03, Vol.29 (4), p.618-623

2020

Volltextzugriff (PDF)

1 – 25 von 2.256

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.906)
Mit Volltextzugriff
(1.888)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

4 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(10)

Menü

Weitere Dienste

Einstellungen

Self-Exciting Fluid Dynamos

The sigma-1 receptor modulates methamphetamine dysregulation of dopamine neurotransmission

Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate versus ritonavir-boosted atazanavir plus co-formulated emtricitabine and tenofovir disoproxil fumarate for initial treatment of HIV-1 infection: a randomised, double-blind, phase 3, non-inferiority trial

Membrane potential shapes regulation of dopamine transporter trafficking at the plasma membrane

Brief Report: Long-Term (96-Week) Efficacy and Safety After Switching From Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in HIV-Infected, Virologically Suppressed Adults

Incidence of AIDS-Defining Opportunistic Infections in a Multicohort Analysis of HIV-infected Persons in the United States and Canada, 2000–2010

Once-daily dolutegravir versus darunavir plus ritonavir for treatment-naive adults with HIV-1 infection (FLAMINGO): 96 week results from a randomised, open-label, phase 3b study

The two Na+ sites in the human serotonin transporter play distinct roles in the ion coupling and electrogenicity of transport

SLC6 transporters: Structure, function, regulation, disease association and therapeutics

Progression of Carotid Intima-Media Thickness in a Contemporary Human Immunodeficiency Virus Cohort

Viscous Thread Falling on a Spinning Surface

Human Serotonin Transporter Coding Variation Establishes Conformational Bias with Functional Consequences

Tyr-95 and Ile-172 in Transmembrane Segments 1 and 3 of Human Serotonin Transporters Interact to Establish High Affinity Recognition of Antidepressants

IMPROVE: a feature model to predict neoepitope immunogenicity through broad-scale validation of T-cell recognition

Stereoselective inhibition of serotonin transporters by antimalarial compounds

Immunologic predictors of coronary artery calcium progression in a contemporary HIV cohort

Increasing procaspase 8 expression using repurposed drugs to induce HIV infected cell death in ex vivo patient cells

Angiotensin converting enzyme inhibitor and HMG-CoA reductase inhibitor as adjunct treatment for persons with HIV infection: a feasibility randomized trial

Intravenous Fat Emulsion Does Not Significantly Alter Clotting Markers in Dabigatran-Treated Blood

Guidelines for the Evaluation and Management of Dyslipidemia in Human Immunodeficiency Virus (HIV)-Infected Adults Receiving Antiretroviral Therapy: Recommendations of the HIV Medicine Association of the Infectious Disease Society of America and the Adult AIDS Clinical Trials Group

Post-translational mechanisms in psychostimulant-induced neurotransmitter efflux

CD4+ count and risk of non-AIDS diseases following initial treatment for HIV infection

Monocyte-Activation Phenotypes Are Associated With Biomarkers of Inflammation and Coagulation in Chronic HIV Infection

Taurine treatment of retinal degeneration and cardiomyopathy in a consanguineous family with SLC6A6 taurine transporter deficiency

Suchergebnisse filtern